Class IITerminated in FDA datasetOct 30, 2013

Houston Enzymes TriEnza with DPP IV Activity, Broad-Spectrum Enzyme Product for general Digestive Support, packaged in 90-(SKU 53379) and 180-(SKU 53380) capsule bottles. The firm name on…

Recalling firm: National Enzyme Co

Why it was recalled

Firm is recalling dietary supplements containing a raw material which may contain >0.3 ppb chloramphenicol

Check the codes ↓

The exact product

Houston Enzymes TriEnza with DPP IV Activity, Broad-Spectrum Enzyme Product for general Digestive Support, packaged in 90-(SKU 53379) and 180-(SKU 53380) capsule bottles. The firm name on the label is Houston Nutraceuticals, Inc. (HNI), Siloam Springs, AR (2) 9212 TRIENZA Bulk Capsules (SKU 91980) packaged in varying quantities in poly bags within corrugated containers.

Check the codes

Compare these FDA-provided codes, lot numbers or dates with the product you have.

Match the product, size and code together. A similar name alone does not identify your batch.

Original FDA code information

Lot Numbers: 53379030, 53379031, 53379032, 53379034, 53379035, 53379036, 53379037, 53379038, 53379039, 53379040, 53379041, 53380079, 53380081, 53380083, 53380085, 53380086, 53380087, 53380088, 53380089, 53380090, 53380091, 53380092, 53380093, 53380094, 53380095, 53380096, 53380097, 53380098, 53380099, 53380100, 53380101, 53380102, 53380103, 53380104, 53380105, 53380106, 53380107, 53380108, 53380109, 53380110, 53380111, 53380113, 53380114, 91980002, 91980003, and 91980004

Recall details

Recall number
F-0734-2014
Event ID
66658
FDA status
Terminated
Initiated
Oct 30, 2013
Reported
Dec 25, 2013
Classified
Dec 13, 2013
Terminated
Mar 3, 2015
Quantity
54,887 bottles, and 327,139 bulk capsules
Location
Forsyth, MO, United States
Initiation type
Voluntary: Firm initiated
Notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Where it was distributed

Domestic distribution of the product is nationwide with direct accounts in 27 states in all geographical regions. Foreign distribution consists of direct accounts in the following countries: Canada, China, Malaysia, Norway, Slovakia, South Korea, Sweden, Taiwan, and the United Kingdom.

FDA source record · F-0734-2014

Data updated September 16, 2026. View official FDA data ↗

A missing code match is not a guarantee of safety. Follow official FDA and manufacturer guidance.